Ingevity Corporation Reports $35.3 Million Net Income in Q2 2026, Revenue Declines 5%

Ingevity Corporation reported a net income of $35.3 million for the second quarter of 2026, a significant recovery from a net loss of $146.5 million in the same period last year. The company’s revenue for the quarter was $314.1 million, down 5% from $331.5 million in the prior year, primarily due to the divestiture of its road markings product line. For the first half of 2026, Ingevity's net income was $95.1 million, compared to a loss of $126.0 million in the first half of 2025, with total revenue decreasing slightly from $579.4 million to $572.1 million.

The decline in revenue was attributed to a 9% decrease in sales volume, which was partially offset by favorable pricing and sales mix adjustments. The Performance Materials segment saw a 4% increase in net sales to $160.6 million, driven by higher volumes and improved pricing. Conversely, the Pavement Technologies segment experienced a 22% decline in sales to $104.2 million, largely due to the aforementioned divestiture. The Advanced Polymer Technologies segment reported a 14% increase in sales to $49.3 million, benefiting from higher prices and a favorable product mix.

In terms of operational changes, Ingevity completed the sale of its industrial specialties product line on January 1, 2026, and the road markings product line on April 15, 2026. These divestitures were part of a strategic shift to streamline operations and focus on core segments. The company also recorded a long-lived asset impairment charge of $32.1 million in the Advanced Polymer Technologies segment, reflecting a reassessment of asset values amid ongoing market conditions.

Looking ahead, Ingevity has raised its full-year adjusted EBITDA outlook, projecting it to be between $380 million and $400 million for 2026. The company expects net sales to range from $1.05 billion to $1.15 billion, with growth anticipated in the Performance Materials and Advanced Polymer Technologies segments. The effective tax rate is expected to be between 22% and 24%, and the company plans to maintain capital expenditures in the range of $40 million to $60 million. Ingevity's liquidity remains strong, with cash and cash equivalents totaling $97.4 million as of June 30, 2026, and undrawn capacity under its revolving credit facility at $246.9 million.